| dailymed-drugs:3935 | dailymed-instance:boxedWarn... | WARNING: TOXICITY IN HEPATIC IMPAIRMENT: IXEMPRA in combination with capecitabine is contraindicated in patients with AST or ALT>2.5 x ULN or bilirubin>1 x ULN due to increased risk of toxicity and neutropenia-related death [see Contraindications (4) and Warnings and Precautions (5.3)]. | lld:dailymed |
